GLAUCOTECH
TO PROTECT, PRESERVE AND RESTORE THE VISION
We reach beyond the blindness Ocular innovations by gene therapies
Phone number
+48 530 813 996
About us
GlaucoTech is a Biotech Company focused on preclinical drug development for various optic neuropathies. We are mostly interested in glaucomatous optic neuropathy, Leber’s hereditary optic neuropathy and ischemic neuropathies.
GlaucoTech aims to lead preclinical and early phase clinical studies to introduce novel, sophisticated therapeutic strategies for non-treatable diseases of optic nerve...
Meet our team
Our research interests concern the molecular aspects of the pathomechanism of optic neuropathy, especially glaucoma
the mechanisms of neurodegeneration as well as neuroprotection and neuroregeneration of retinal ganglion cells in the course of glaucomatous neuropathy
experimental neuroprotective therapies in glaucoma. Our team is developing AAV-based platform for ocular delivery enabling to carry out various gene-based therapies
Our History
Our glaucoma research history started back in 2010. The originator and co-founder of GlaucoTech is Docent Adrian Smędowski - internationally recognized ophthalmologist, scientist and physiologist. Docent Smedowski is the author of an innovative discovery about a new type of synaptic connections within the optic nerve. Together with his team, he described a new theory of glaucoma development, based on the dysfunction of endogenous neuroprotective mechanisms of the retinal ganglion cells. He is currently conducting research on experimental gene therapy in glaucoma, retinitis pigmentosa and retinal/optic nerve ischemia.
We believe that innovation is the starting point for spontaneous growth, where creativity combined with good ideas, can leverage any business.
Team of Experts
We Love What We Do!
Adrian Smedowski MD PhD FEBO
Associate Professor at Medical University of Silesia
Ophthalmologist
Physiologist
Experimental Ophthalmology Researcher
Principal Investigator at Visual Neuroscience Lab at Medical University of Silesia
Joanna Lewin-Kowalik MD PhD
Professor at Medical University of Silesia
Physiologist
Experimental Ophthalmology Researcher
Pioneer of Visual Neuroscience Research in Poland
Slawomir Kosciak
Healthcare Angel Investor
Equity Capital Markets
Anna Pacwa MSc
Experimental Ophthalmology Researcher
Molecular Biology Specialist
GLP, GCP specialist
Clinical Trials specialist
Karolina Mazij MSc
Media and Information Technology
Clinical Trials specialist
GCP specialist
Katarzyna Jurzak MSc
Have any Questions?
GlaucoTech is a Biotech Company focused on preclinical drug development for various optic neuropathies. So the site should relate to DNA, ophthalmology, drug development etc